Dietary Supplement Bill Would Require Companies to Report Adverse Reactions to FDA


Statement of CSPI Legal Affairs Director Bruce Silverglade

June 21, 2006

Manufacturers of dietary supplements should absolutely be required to report serious adverse reactions to the Food and Drug Administration. Thatís why the Center for Science in the Public Interest strongly supports the bipartisan legislation sponsored by Senators Hatch, Durbin, Enzi, Harkin and Kennedy. Reporting of adverse reactions will make it easier for the FDA to identify problem ingredients and to protect consumers.

Under the current voluntary system, the FDA receives less than 1 percent of all reports of adverse reactions to dietary supplements. We urge the Senate to approve this legislation promptly and hope that the House can pass a companion bill before the end of the current session. We also encourage Congress to provide sufficient funding to the FDA so that the Agency can timely respond to reports of adverse reactions and protect the public from any hazardous products.

 

Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now

NAH

NAH

Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues


Cover Story: Tip of the Iceberg: Most people With Prediabetes Don't Know It


Special Feature: Food Poisoning


Brand-Name Rating: Freekeh


NAH
Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.

BBB
Guidestar